Cargando…

Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status

Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event...

Descripción completa

Detalles Bibliográficos
Autores principales: Currie, Craig J., Berni, Ellen R., Berni, Thomas R., Jenkins-Jones, Sara, Sinsakul, Marvin, Jermutus, Lutz, Ambery, Philip, Jain, Meena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713399/
https://www.ncbi.nlm.nih.gov/pubmed/31461449
http://dx.doi.org/10.1371/journal.pone.0221044
_version_ 1783446869895020544
author Currie, Craig J.
Berni, Ellen R.
Berni, Thomas R.
Jenkins-Jones, Sara
Sinsakul, Marvin
Jermutus, Lutz
Ambery, Philip
Jain, Meena
author_facet Currie, Craig J.
Berni, Ellen R.
Berni, Thomas R.
Jenkins-Jones, Sara
Sinsakul, Marvin
Jermutus, Lutz
Ambery, Philip
Jain, Meena
author_sort Currie, Craig J.
collection PubMed
description Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event (MACE; myocardial infarction or stroke) in CKD patients with and without diabetes. Data were from a linked database of UK electronic health records. Individuals with CKD and no prior MACE were classified as type 1 diabetes (T1DM; n = 164), type 2 diabetes (T2DM; n = 9,711), and non-diabetes (non-DM; n = 75,789). Monthly updated time-dependent Cox proportional hazard models were constructed to calculate adjusted hazard ratios (aHRs) for progression to MACE from first record of abnormal eGFR or proteinuria (index date). In non-DM, aHRs (95% CIs) by baseline eGFR category (referent G2) were G1: 0.70 (0.55–0.90), G3a: 1.28 (1.20–1.35), G3b: 1.64 (1.52–1.76), G4: 2.19 (1.98–2.43), and G5: 3.12 (2.44–3.99), and by proteinuria category (referent A1) were A2: 1.13 (1.00–1.28), A2/3 (severity indeterminable): 1.58 (1.28–1.95), and A3: 1.64 (1.38–1.95). In T2DM, aHRs were G1: 0.98 (0.72–1.32), G3a: 1.18 (1.03–1.34), G3b: 1.31 (1.12–1.54), G4: 1.87 (1.53–2.29), G5: 2.87 (1.82–4.52), A2: 1.22 (1.04–1.42), A2/3: 1.45 (1.17–1.79), and A3: 1.82 (1.53–2.16). Low numbers in T1DM precluded analysis. Modelling T2DM and non-DM together, aHRs were, respectively, G1: 3.23 (2.38–4.40) and 0.70 (0.55–0.89); G2: 3.18 (2.73–3.70) and 1.00 (referent); G3a: 3.65 (3.13–4.25) and 1.28 (1.21–1.36); G3b: 4.01 (3.40–4.74) and 1.65 (1.54–1.77); G4: 5.78 (4.70–7.10) and 2.21 (2.00–2.45); G5: 9.00 (5.71–14.18) and 3.14 (2.46–4.00). In conclusion, reduced eGFR and proteinuria were independently associated with increased risk of MACE regardless of diabetes status. However, the risk of MACE in the same eGFR state was 4.6–2.4 times higher in T2DM than in non-DM.
format Online
Article
Text
id pubmed-6713399
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-67133992019-09-04 Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status Currie, Craig J. Berni, Ellen R. Berni, Thomas R. Jenkins-Jones, Sara Sinsakul, Marvin Jermutus, Lutz Ambery, Philip Jain, Meena PLoS One Research Article Diabetes plays an important role in the complex relationship between chronic kidney disease (CKD) and cardiovascular disease. This retrospective observational study compared the influence of estimated glomerular filtration rate (eGFR) and proteinuria on the risk of major adverse cardiovascular event (MACE; myocardial infarction or stroke) in CKD patients with and without diabetes. Data were from a linked database of UK electronic health records. Individuals with CKD and no prior MACE were classified as type 1 diabetes (T1DM; n = 164), type 2 diabetes (T2DM; n = 9,711), and non-diabetes (non-DM; n = 75,789). Monthly updated time-dependent Cox proportional hazard models were constructed to calculate adjusted hazard ratios (aHRs) for progression to MACE from first record of abnormal eGFR or proteinuria (index date). In non-DM, aHRs (95% CIs) by baseline eGFR category (referent G2) were G1: 0.70 (0.55–0.90), G3a: 1.28 (1.20–1.35), G3b: 1.64 (1.52–1.76), G4: 2.19 (1.98–2.43), and G5: 3.12 (2.44–3.99), and by proteinuria category (referent A1) were A2: 1.13 (1.00–1.28), A2/3 (severity indeterminable): 1.58 (1.28–1.95), and A3: 1.64 (1.38–1.95). In T2DM, aHRs were G1: 0.98 (0.72–1.32), G3a: 1.18 (1.03–1.34), G3b: 1.31 (1.12–1.54), G4: 1.87 (1.53–2.29), G5: 2.87 (1.82–4.52), A2: 1.22 (1.04–1.42), A2/3: 1.45 (1.17–1.79), and A3: 1.82 (1.53–2.16). Low numbers in T1DM precluded analysis. Modelling T2DM and non-DM together, aHRs were, respectively, G1: 3.23 (2.38–4.40) and 0.70 (0.55–0.89); G2: 3.18 (2.73–3.70) and 1.00 (referent); G3a: 3.65 (3.13–4.25) and 1.28 (1.21–1.36); G3b: 4.01 (3.40–4.74) and 1.65 (1.54–1.77); G4: 5.78 (4.70–7.10) and 2.21 (2.00–2.45); G5: 9.00 (5.71–14.18) and 3.14 (2.46–4.00). In conclusion, reduced eGFR and proteinuria were independently associated with increased risk of MACE regardless of diabetes status. However, the risk of MACE in the same eGFR state was 4.6–2.4 times higher in T2DM than in non-DM. Public Library of Science 2019-08-28 /pmc/articles/PMC6713399/ /pubmed/31461449 http://dx.doi.org/10.1371/journal.pone.0221044 Text en © 2019 Currie et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Currie, Craig J.
Berni, Ellen R.
Berni, Thomas R.
Jenkins-Jones, Sara
Sinsakul, Marvin
Jermutus, Lutz
Ambery, Philip
Jain, Meena
Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
title Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
title_full Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
title_fullStr Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
title_full_unstemmed Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
title_short Major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
title_sort major adverse cardiovascular events in people with chronic kidney disease in relation to disease severity and diabetes status
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6713399/
https://www.ncbi.nlm.nih.gov/pubmed/31461449
http://dx.doi.org/10.1371/journal.pone.0221044
work_keys_str_mv AT curriecraigj majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT berniellenr majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT bernithomasr majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT jenkinsjonessara majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT sinsakulmarvin majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT jermutuslutz majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT amberyphilip majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus
AT jainmeena majoradversecardiovasculareventsinpeoplewithchronickidneydiseaseinrelationtodiseaseseverityanddiabetesstatus